We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Virotec Intl | LSE:VTI | London | Ordinary Share | GB00B15PVR02 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:6208R Virotec International PLC 04 April 2008 Virotec International plc 4 April 2008 VIROTEC INTERNATIONAL PLC ("Virotec" or "the Company") Share price movement and approach from Hydrodec Group PLC The Board of Virotec have noted the sharp rise in the Company's ordinary share price and the high level of turnover in their shares yesterday. On 30 January 2008 the Company announced that it had received approaches that might or might not lead to an offer for the Company. Discussions with one particular party have been on-going since that date. The Board was informed by Hydrodec Group PLC ("Hydrodec") on 3 April 2008 that Hydrodec had bought 7.75 million Virotec ordinary shares at an average price of 7.85 pence per share. This purchase represents approximately 2.93 per cent. of the issued share capital of Virotec. Hydrodec also informed the Board of Virotec of its intention to make an all share offer for the Company. On the basis of the share price of Hydrodec at the close of business yesterday, the indicative offer would value each Virotec ordinary share at approximately 12p per share. Hydrodec further notified the Board of Virotec that it had received support from shareholders in Virotec, representing in aggregate just below 30 per cent. of the issued share capital of Virotec. The Board of Virotec is consulting with its advisers and will make a further announcement shortly. For further information please contact: Virotec International plc Bruno Bamonte, Chief Financial Officer +44 7730 663962 Angus Craig, Company Secretary +61 75573 3373 Arden Partners plc Chris Hardie/Matthew Armitt +44 207 398 1630 VIROTEC INTERNATIONAL plc Company Number 5796515 www.virotec.com This information is provided by RNS The company news service from the London Stock Exchange END SPMGCGDSIDGGGIS
1 Year Virotec Chart |
1 Month Virotec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions